NPDUIS Advisory Committee

Chair

Tanya Potashnik
Director, Policy and Economic Analysis Branch
Patented Medicine Prices Review Board

Members

Christine Voggenreiter
Director, Economic Analysis, Pharmaceutical Services Division
British Columbia Ministry of Health

Andrea Nagle
Director, Professional and Industry Relations
Pharmaceuticals and Supplementary Health Benefits Branch, Government of Alberta

Andrea Laturnas
Pharmaceutical Pricing and Value Manager, Pharmaceutical Policy and Appropriateness Unit
Drug Plan and Extended Benefits Branch, Saskatchewan Ministry of Health

Kathy McDonald
Pharmaceutical Consultant/MDSTC Secretary, Provincial Drug Program
Manitoba Health

Angie Wong
Senior Manager
Pharmaceutical Services Coordination, Ontario Public Drugs Programs

Kevin Pothier
Director, Business Management, Pharmaceutical Services
New Brunswick Department of Health

Holly Chisholm
Senior Economist
Nova Scotia Department of Health

Bonnie Corish
Pharmacist Consultant, Health PEI
PEI Pharmacare

Brenda Wild
Clinical Pharmacist, Department of Health and Community Services
Government Newfoundland and Labrador

Dorothea Talsma
Manager, Extended Benefits & Pharmaceutical Programs, Health & Hearing Services
Government of Yukon

Susan Pierce
Manager, Pharmacy Group, Benefit Management Division
Non-Insured Health Benefits Directorate, Health Canada

Michael Gardner
A/Director, Program Analysis Division
Non-Insured Health Benefits Directorate, Health Canada

Nelson Millar
Senior Policy Analyst, Office of Pharmaceuticals Management Strategies
Strategic Policy Branch, Health Canada

Elena Lungu
Manager, NPDUIS
Patented Medicine Prices Review Board

Observers

Michele Arthur
Program Lead, NPDUIS
Canadian Institute for Health Information

Karen M. Lee
Director, Health Economics
Canadian Agency for Drugs and Technologies in Health